Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Retained Earnings (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Retained Earnings data on record, last reported at $128.0 million in Q3 2025.

  • For Q3 2025, Retained Earnings fell 4.55% year-over-year to $128.0 million; the TTM value through Sep 2025 reached $128.0 million, down 4.55%, while the annual FY2024 figure was $129.3 million, 6.53% down from the prior year.
  • Retained Earnings reached $128.0 million in Q3 2025 per UTMD's latest filing, up from $126.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $139.0 million in Q1 2024 and bottomed at $112.9 million in Q1 2021.
  • Average Retained Earnings over 5 years is $126.5 million, with a median of $128.0 million recorded in 2025.
  • Peak YoY movement for Retained Earnings: rose 10.89% in 2023, then decreased 7.76% in 2025.
  • A 5-year view of Retained Earnings shows it stood at $115.3 million in 2021, then grew by 9.27% to $126.0 million in 2022, then grew by 9.79% to $138.3 million in 2023, then dropped by 6.53% to $129.3 million in 2024, then fell by 1.04% to $128.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were $128.0 million in Q3 2025, $126.9 million in Q2 2025, and $128.2 million in Q1 2025.